Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.
Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R.
Morishima Y, et al. Among authors: ogura m.
Int J Hematol. 2004 Oct;80(3):261-6. doi: 10.1532/ijh97.04074.
Int J Hematol. 2004.
PMID: 15540902
Clinical Trial.